Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ichor Life Sciences Announces Launch of Ichor Clinical Trial Services


News provided by

Ichor Life Sciences

Nov 14, 2023, 07:30 ET

Share this article

Share toX

Share this article

Share toX

Ichor Clinical
Ichor Clinical

Ichor Life Sciences, a full-service contract research organization (CRO) and longevity biotechnology company, today announced the launch of Ichor Clinical Trial Services. With the founding of Ichor Clinical, the company is now able to serve biotechnology and pharmaceutical clients from early preclinical studies through late-stage clinical trials and FDA approval.

LAFAYETTE, N.Y., Nov. 14, 2023 /PRNewswire-PRWeb/ -- Ichor Life Sciences, a full-service contract research organization (CRO) and longevity biotechnology company, today announced the launch of Ichor Clinical Trial Services. With the founding of Ichor Clinical, the company is now able to serve biotechnology and pharmaceutical clients from early preclinical studies through late-stage clinical trials and FDA approval.

Ichor Clinical offers a spectrum of customized clinical trial solutions, ranging from individual service options to full CRO assistance. Centered on solving each client's unique challenges, the team specializes in critical areas such as protocol design, site identification and qualification, and recruitment and retention strategies. Ichor's agile, relationship-focused approach allows the company to address complexities that may be difficult for larger, more standardized CROs, including assisting ongoing trials when they encounter enrollment hurdles or operational complications, restoring the trial's trajectory toward success. Ichor's preclinical offerings include protein services, pharmacology and discovery services, and consulting services.

The launch of Ichor Clinical in Ichor's ecosystem creates a premium offering, providing biotechnology and pharmaceutical clients with a single partner to navigate preclinical work through clinical trials with customized and flexible engagement options, said Ichor Founder and CEO Kelsey Moody, PhD.

Post this

"The launch of Ichor Clinical as part of the Ichor ecosystem creates a premium offering in the industry, providing biotechnology and pharmaceutical clients with a single partner to navigate preclinical work through clinical trials with customized and flexible engagement options," said Ichor Life Sciences Founder and CEO Kelsey Moody, PhD, MBA. "As both a CRO and longevity drug development company, Ichor brings together a unique combination of expertise that allows our team to understand clients' needs and develop innovative solutions that address their most difficult challenges. We look forward to serving our clinical trial clients with the same caliber of personalized, relationship-first services that clients have come to expect and trust in our preclinical services."

Lisa Sonneborn, MA, LMHC, serves as President of Ichor Clinical Trial Services. Sonneborn previously founded and served as CEO of Clarity Clinical Research, which was acquired by the world's largest site management organization (SMO) in 2021. She is well known and respected in the industry, particularly as a leader in clinical trial operations for Alzheimer's disease and NASH, having participated in countless industry-sponsored studies. Ichor Clinical employees have extensive sponsor and site experience, providing them with a deep understanding of every aspect of clinical trials.

"Having worked on numerous clinical trials and gained insight into the complex issues that sponsors and sites often face, Ichor Clinical is well-positioned to anticipate and resolve challenges, ensuring the efficient and effective progression of trials," said Sonneborn. "We concentrate on tailoring solutions to our clients' specific needs by identifying key issues, ultimately enabling companies to advance their pipelines and contribute to building a healthier world."

The full suite of services that Ichor now offers is more critical than ever as the CRO industry undergoes consolidation. Through strategic collaborations with renowned institutions, key opinion leaders, and regulatory authorities worldwide, Ichor has strong partnerships that enhance the company's capacity to support even the most challenging projects. This provides Ichor's clients with access to cutting-edge technologies, world-class facilities, and diverse patient populations.

About Ichor Life Sciences
Ichor Life Sciences is a full-service, end-to-end contract research organization (CRO) and longevity biotechnology company. Founded in 2013 in Upstate New York, Ichor's CRO services help biotechnology and pharmaceutical companies solve their most difficult challenges—from preclinical studies to late-stage clinical trials and FDA approval—using a personalized approach that puts relationships and science first.

As a longevity biotechnology company, Ichor aims to help people live longer, healthier lives by developing therapies with the potential to treat age-related diseases. It is the first and oldest longevity-focused venture studio, as well as home to the oldest industry PhD program for drug discovery for longevity. By bringing together its expertise in drug development and as a CRO within its venture portfolio, Ichor is developing promising treatments that have the potential to transform how we age and address unmet needs in the process.

With its breadth of expertise, Ichor is pioneering the longevity and anti-aging biotechnology industry while empowering CRO clients to rapidly advance their research and development programs. To learn more, please visit https://ichorlifesciences.com/ and follow Ichor Life Sciences on LinkedIn.

Media Contact

Virgie Townsend, Strategic Communications, 315-802-6056, Virgie@stratcomllc.com

SOURCE Ichor Life Sciences

Modal title

Ichor Life Sciences
Ichor Life Sciences
Ichor Life Sciences

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.